Thu, Jan 29, 2015, 12:05 AM EST - U.S. Markets open in 9 hrs 25 mins


% | $
Quotes you view appear here for quick access.

Gilead Sciences Inc. Message Board

  • ccharles792 ccharles792 Sep 9, 2012 8:11 PM Flag

    Cramer " QCOR Set To Shoot Through The ROOF" link

    Mad Money Recap September 7, 2012 9:00 p.m. EDT By: Kyle Nofuente
    Cramer talks about QuestCor Pharma. (QCOR). In 2005, QCOR was a .50 stock and as of today, is alittle above $51. The company has one drug on the market called Acthar, a sort of “wonder drug” gel, that treats 19 (yes, 19) different conditions. But if you’ve been following the stock, you know it got beat up in July. Why? Cramer explains that rumors on the web “revealed” that a cheaper, generic drug to Acthar was coming and the shortsellers knocked the stock down. But if you did your homework, then you’d also know (as Cramer tells us today) that getting a new drug approved to market by the FDA takes two years. Plus, to get a new drug into the market that treats 19 different conditions requires 19 different clinical trails – no easy feat. As Acthar is an ophan drug – a drug treating a small segment of people that the gov’t throws incentives at – QCOR is set to “shoot through the roof.”

102.45-2.58(-2.46%)Jan 28 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Facebook, Inc.
NASDAQWed, Jan 28, 2015 4:00 PM EST
Exelixis, Inc.
NASDAQWed, Jan 28, 2015 4:00 PM EST